These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19916100)

  • 1. Representation of African Americans in direct-to-consumer pharmaceutical commercials: a content analysis with implications for health disparities.
    Ball JG; Liang A; Lee WN
    Health Mark Q; 2009; 26(4):372-90. PubMed ID: 19916100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
    Applequist J; Ball JG
    Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads.
    Aikin KJ; Betts KR; Boudewyns V; Johnson M; Davis CN
    Res Social Adm Pharm; 2020 Sep; 16(9):1237-1247. PubMed ID: 31838056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
    Faerber AE; Kreling DH
    J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Message strategies in direct-to-consumer pharmaceutical advertising: a content analysis using Taylor's six-segment message strategy wheel.
    Tsai WH; Lancaster AR
    Health Mark Q; 2012; 29(3):239-55. PubMed ID: 22905945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-consumer advertising affects provider / patient relationship.
    Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "For the good of the patient," survey of the physicians of the National Medical Association regarding perceptions of DTC advertising, Part II, 2006.
    Morris AW; Gadson SL; Burroughs V
    J Natl Med Assoc; 2007 Mar; 99(3):287-93. PubMed ID: 17393955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
    Klara K; Kim J; Ross JS
    J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-to-consumer advertising of prescription drugs.
    Frosch DL; Grande D
    LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and ethnic disparities in response to direct-to-consumer advertising.
    Lee D; Begley CE
    Am J Health Syst Pharm; 2010 Jul; 67(14):1185-90. PubMed ID: 20592325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/ethnic and income disparities in child and adolescent exposure to food and beverage television ads across the U.S. media markets.
    Powell LM; Wada R; Kumanyika SK
    Health Place; 2014 Sep; 29():124-31. PubMed ID: 25086271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of presentation modality in direct-to-consumer (DTC) prescription drug television advertisements.
    Wogalter MS; Shaver EF; Kalsher MJ
    Appl Ergon; 2014 Sep; 45(5):1330-6. PubMed ID: 24377979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do dissonant ad visuals cause consumers to discount prescription drug side effects?
    Hagenbuch D
    Health Mark Q; 2019; 36(4):337-353. PubMed ID: 31646956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.
    Sullivan HW; Aikin KJ; Poehlman J
    Health Commun; 2019 Feb; 34(2):212-219. PubMed ID: 29125325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "When diet and exercise are not enough": an examination of lifestyle change inefficacy claims in direct-to-consumer advertising.
    Byrne S; Niederdeppe J; Avery RJ; Cantor J
    Health Commun; 2013; 28(8):800-13. PubMed ID: 23444915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.